All News

Globus Medical Reports Second Quarter 2018 Results

AUDUBON, Pa., Aug. 01, 2018 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2018. Worldwide sales were $173.4 million, an increase of 13.8% as reported Second quarter net income was $45.0 million, an increase of 56.9% Diluted earnings per share […]

The global orthopedic devices market size is expected to reach USD 43.1 billion by 2024

NEW YORK, August 1, 2018 /PRNewswire/ — Orthopedic Devices Market Size, Share & Trends Analysis Report By Application (Hip, Knee, Spine, Dental, Craniomaxillofacial, Sports Injuries, Extremities, and Trauma), By Product, And Segment Forecasts, 2018 – 2024Read the full report: https://www.reportlinker.com/p05479699 The global orthopedic devices market size is expected to reach USD 43.1 billion by 2024, according to a study by […]

Osiris Therapeutics, Inc. to Re-list on The Nasdaq Global Market on August 1, 2018

COLUMBIA, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, today announced that The Nasdaq Stock Market LLC has approved its application to list its common stock on The Nasdaq Global Market. Osiris’s common stock […]

NuVasive Announces Second Quarter 2018 Financial Results

SAN DIEGO, July 31, 2018 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced financial results for the quarter ended June 30, 2018. Second Quarter 2018 Highlights Revenue increased 8.5% to $281.6 million, or 7.7% on a constant currency basis; GAAP operating profit margin of 10.1%; […]

Histogenics Corporation Appoints E. Lynne Kelley, M.D., FACS As Chief Medical Officer

WALTHAM, Mass., July 31, 2018 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies (RCTs) that may offer rapid-onset pain relief and restored function, today announced the appointment of E. Lynne Kelley, M.D., FACS as its Chief Medical Officer. Dr. Kelley brings more than 20 years of executive […]

OrthoPediatrics Announces Expanded Indication for FIREFLY® Pedicle Screw Navigation Guides

WARSAW, Ind., July 31, 2018 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce that FIREFLY® Pedicle Screw Navigation Guides (“FIREFLY”) received additional FDA 510(k) clearance for an expanded indication to include S2AI [screw] trajectory for sacral-iliac fixation in complex spinal reconstruction surgeries, including scoliosis. […]

SeaSpine Reports Second Quarter 2018 Financial Results

CARLSBAD, Calif., July 30, 2018 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the quarter ended June 30, 2018 and updated its financial outlook for 2018. Summary Second Quarter 2018 Financial Results and Recent Accomplishments Revenue of […]

The global bone grafts and substitutes market size is expected to reach USD 3.9 billion by 2025

LONDON, July 31, 2018 /PRNewswire/ — Bone Grafts and Substitutes Market Size, Share & Trends Analysis Report By Material Type (Natural, Synthetic), By Application Type (Spinal Fusion, Craniomaxillofacial, Long Bone), By Region, And Segment Forecasts, 2018 – 2025.Download the full report: https://www.reportbuyer.com/product/5479697 The global bone grafts and substitutes market size is expected to reach USD 3.9 billion by 2025, according to a […]

Episurf Medical has received initial feedback from the US FDA on the IDE application for the Episealer® knee implant

MON, JUL 30, 2018 08:30 CET Episurf Medical (NASDAQ: EPIS B) today announces that the company has received initial feedback from the US Food and Drug Administration (FDA) on the Investigational Device Exemption (IDE) application for the Episealer® knee implant that was submitted in June.  The company filed the IDE application to get approval to […]

CloudMedx Working With UCSF to Create AI Models for Improving Patient Outcomes After Joint Replacement Surgery

PALO ALTO, Calif., July 30, 2018 (GLOBE NEWSWIRE) — CloudMedx, a healthcare artificial intelligence (AI) company based in Palo Alto, Calif., announced today a research collaboration with the UCSF Department of Orthopaedic Surgery to study how patient-generated health care data collected from consumer-grade wearable sensors may predict clinical outcomes following hip and knee replacement surgery. By […]

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1